REACH Authorization

REACH Authorization
5
//
12/20/2023

Postponement of the DEHP ban in medical devices: new dates

The European Commission recently announced a postponement of the ban on the use of bis(2-ethylhexyl) phthalate (DEHP) in medical devices (MDs).
REACH Authorization
26
//
12/20/2023

The EC authorizes certain uses of 4-tert-OPnEO and 4-NPnEO

On June 13, 2023, the European Commission (EC) published in the Official Journal of the European Union (EU) several authorization decisions concerning uses of 4-tert-OPnEO and 4-NPnEO, Substances of Very High Concern (SVHC). The authorizations concern QIAGEN, STAT-Dx Life and QIAGEN Distribution.
REACH Authorization
22
//
12/20/2023

8 SVHCs recommended for REACH authorization list, including lead

The ECHA has recommended to the European Commission (EC) the addition of 8 SVHC (Substance of Very High Concern) to the authorization list (Annex XIV) of REACH (Registration, Evaluation and Authorization of Chemicals).
REACH Authorization
31
//
12/20/2023

Authorisations and restrictions: how legislation promotes substituting harmful substances

A recent ECHA study shows that regulations are the main driver for the substitution of harmful substances. Further proof that regulation contributes to and propels innovation, EcoMundo tells you more about this study.
REACH Authorization
14
//
12/20/2023

11 substances added to REACH annex XIV

The European Commission recently officially adopted the regulation amending REACH Regulation (EC) N° 1907/2006 with the addition of 11 new entries to the list of substances subject to authorisation. It will come into force on 27th February. By comparison with the draft regulation published in February 2019, one substance was removed.
REACH Authorization
19
//
12/20/2023

Upstream applications for CrVI: what’s next? EcoMundo clears things up

In the current context, upstream authorisation dossiers for hexavalent chromium are uncertain. To help you understand as best as possible, EcoMundo’s experts share their point of view.